Loading clinical trials...
Loading clinical trials...
Prostate Cancer (PCa) is the second most common malignancy and the 5th common cause of cancer-related mortality in men worldwide. The majority of patients with PCa is diagnosed with potentially curabl...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Istituto Clinico Humanitas
Collaborators
NCT07189598 · High Risk Prostate Cancer
NCT07208240 · High Risk Prostate Cancer
NCT05406999 · Neoadjuvant Therapy, High Risk Prostate Cancer, and more
NCT07393867 · Intermediate Risk Prostate Cancer, High Risk Prostate Cancer, and more
NCT03537391 · High Risk Prostate Cancer
Humanitas Gavazzeni
Bergamo, Bergamo
Humanitas PIO X
Milan, Milan
IRCCS Humanitas Research Hospital
Rozzano, Milan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions